You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IDH-wildtype

Showing 1 - 25 of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Rotterdam (Extended MRI)

Recruiting
  • Glioblastoma
  • Extended MRI
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jul 24, 2023

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

Not yet recruiting
  • Diffuse Astrocytoma, IDH-Mutant
  • +20 more
  • NEO212 Oral Capsule
  • +8 more
  • (no location specified)
Sep 18, 2023

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Jun 26, 2023

Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)

Active, not recruiting
  • Grade III Astrocytoma
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 9, 2022

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

IDH-mutant and IDH-wildtype Glioma Patients After

Recruiting
  • Glioma
  • RS-fMRI
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 8, 2022

Glioblastoma, Glioblastoma, IDH-wildtype Trial in Rome (Biomolecular tumor analysis)

Recruiting
  • Glioblastoma
  • Glioblastoma, IDH-wildtype
  • Biomolecular tumor analysis
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023

Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

Active, not recruiting
  • Glioma of Brain
  • Bern, Switzerland
  • +2 more
Apr 7, 2022

Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Beijing, China
    Peking Union Medical College Hospital
Apr 22, 2023

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Glioblastoma, IDH-wildtype Trial in Rome (Biological biomarker analysis)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Biological biomarker analysis
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Jul 3, 2023

Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

Recruiting
  • Astrocytoma, Grade IV
  • +7 more
    • Valencia, Spain
      Biomedical Data Science Lab. Universitat Politècnica de València
    May 11, 2022

    Gut microBIOME in Glioblastoma Patients Receiving

    Not yet recruiting
    • Glioblastoma, IDH-wildtype
      • (no location specified)
      Apr 5, 2022

      Glioblastoma, IDH-wildtype Trial in France, Italy (Metformin, Radiation IMRT, Temozolomide)

      Not yet recruiting
      • Glioblastoma, IDH-wildtype
      • Suresnes, Hauts De Seine, France
      • +5 more
      Aug 2, 2022

      The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma

      Recruiting
      • Glioblastoma
      • +4 more
      • Tumor resection
      • Tumor biopsy
      • San Francisco, California
      • +7 more
      Nov 18, 2023

      Malignant Glioma of Brain Trial in Chicago (Acetazolamide, Temozolomide)

      Recruiting
      • Malignant Glioma of Brain
      • Chicago, Illinois
        University of Chicago Medical Center
      Apr 1, 2022

      The PALSUR-study: Palliative Care Versus Surgery in High-grade

      Recruiting
      • Glioblastoma
      • +3 more
      • Palliative Care
      • +2 more
      • San Francisco, California
      • +7 more
      Nov 18, 2023

      Supramaximal Resection Versus Maximal Resection for High-Grade

      Recruiting
      • Glioblastoma
      • +11 more
      • Supramaximal resection
      • Maximal safe resection
      • San Francisco, California
      • +7 more
      Nov 1, 2023

      High Grade Astrocytic Tumor, Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma Trial in Rochester (Biospecimen

      Not yet recruiting
      • High Grade Astrocytic Tumor
      • +2 more
      • Biospecimen Collection
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic
      Jul 18, 2022

      MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

      Not yet recruiting
      • MGMT-Methylated Glioblastoma
      • Recurrent Glioblastoma, IDH-Wildtype
      • (no location specified)
      Jun 28, 2022

      Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

      Recruiting
      • Glioblastoma
      • +6 more
      • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
      • Temozolomide and Radiation Alone
      • New York, New York
        Lenox Hill Brain Tumor Center
      May 5, 2022

      Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

      Recruiting
      • Astrocytoma
      • +4 more
      • Mycophenolate Mofetil
      • +3 more
      • Chicago, Illinois
        Northwestern University
      Aug 22, 2022

      Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma

      Recruiting
      • Recurrent Glioblastoma Multiforme (GBM)
      • +3 more
      • Los Angeles, California
      • +4 more
      May 5, 2022